Description
Kliovance 1mg/0.5mg Film-Coated Tablets are used to manage symptoms of oestrogen deficiency in postmenopausal women.
During menopause, the ovaries gradually produce less oestrogen, which can lead to hot flushes, night sweats, disrupted sleep and other uncomfortable symptoms that affect everyday life.
Kliovance contains two hormones:
-
Estradiol 1mg: An oestrogen that replaces declining natural oestrogen levels to help relieve menopause symptoms.
-
Norethisterone Acetate 0.5mg: A progestogen that helps protect the lining of the womb from excessive thickening caused by oestrogen treatment.
Kliovance is a continuous combined HRT, meaning both hormones are taken together every day without a treatment-free break. This approach is generally intended for women whose last natural menstrual period was more than 12 months ago.
Unlike sequential HRT, continuous combined treatment is designed to avoid regular monthly withdrawal bleeding. However, spotting or irregular bleeding may occur, particularly during the first few months.
Kliovance may also be prescribed to prevent osteoporosis in postmenopausal women at increased risk of fractures when other approved osteoporosis treatments are unsuitable.
Product Details
| Detail |
Information |
| Product Name |
Kliovance 1mg/0.5mg |
| Brand |
Kliovance |
| Manufacturer |
Novo Nordisk |
| Active Ingredients |
Estradiol and norethisterone acetate |
| Strength |
Estradiol 1mg + norethisterone acetate 0.5mg |
| Form |
Film-coated tablets |
| Pack Size |
84 tablets (3 × 28) |
| Treatment Type |
Continuous combined HRT |
| Main Use |
Relief of postmenopausal symptoms |
| Administration |
Oral |
| Standard Dosage |
One tablet daily |
| Prescription Required |
Yes |
| Storage |
Do not store above 25°C |
Key Benefits
-
Helps relieve hot flushes and night sweats.
-
Replaces declining oestrogen levels after menopause.
-
Contains a progestogen to help protect the womb lining.
-
Convenient once-daily tablet.
-
Continuous combined treatment without monthly breaks.
-
May help improve menopause-related disruption to sleep and daily activities.
-
May help prevent osteoporosis in selected postmenopausal women.
-
Supplied as 84 tablets, providing 12 weeks of treatment at the standard dose.
Directions
Kliovance should be taken exactly as prescribed by your healthcare professional.
-
Take one tablet once daily, preferably at the same time each day.
-
Swallow the tablet with water.
-
Kliovance can be taken with or without food.
-
Continue taking one tablet every day without a treatment-free break.
-
After finishing a 28-tablet calendar pack, start the next pack immediately.
-
Do not increase or reduce your dose without consulting your doctor.
How to Use the Calendar Pack
Kliovance comes in a calendar dial pack to help you remember your daily medication.
-
Turn the inner disc until the correct day of the week appears beside the indicator.
-
Break the plastic tab and remove the first tablet.
-
Rotate the transparent dial one position clockwise each day.
-
Take only one tablet daily.
What If You Miss a Dose?
-
If fewer than 12 hours have passed since your usual dosing time, take the missed tablet as soon as you remember.
-
If more than 12 hours have passed, skip the missed tablet and take your next tablet at the usual time.
-
Do not take two tablets to make up for a missed dose.
Missing a dose may increase the likelihood of breakthrough bleeding or spotting.
Ingredients
Active Ingredients
Each film-coated tablet contains:
-
Estradiol 1mg, as estradiol hemihydrate.
-
Norethisterone Acetate 0.5mg.
Other Ingredients
Tablet core:
Film coating:
Allergy and intolerance information: Kliovance contains lactose. Patients with certain inherited conditions affecting sugar metabolism should consult their doctor before use.
Side Effects
Like all medicines, Kliovance may cause side effects, although not everyone experiences them.
Very Common Side Effects
May affect more than 1 in 10 people:
-
Breast pain or tenderness.
-
Common Side Effects
May affect up to 1 in 10 people:
-
-
-
Breast swelling or enlargement.
-
Fluid retention and swelling of the arms or legs.
-
-
-
Vaginal inflammation or fungal infections.
-
Depression or worsening of existing depression.
-
Worsening of uterine fibroids.
Uncommon Side Effects
May affect up to 1 in 100 people:
-
Abdominal pain, bloating or flatulence.
-
-
-
Increased facial or body hair.
-
-
-
-
-
Inflammation of a superficial vein.
Serious Side Effects and Risks
Combined HRT may increase the risk of certain conditions, including breast cancer, blood clots, stroke and heart disease. Risks depend on individual health factors and treatment duration.
Seek emergency medical attention if you experience:
-
Sudden chest pain or difficulty breathing.
-
Painful swelling or redness in one leg.
-
Sudden facial weakness, speech difficulties or other stroke symptoms.
-
Swelling of the face, tongue or throat with breathing difficulties.
Stop taking Kliovance and seek prompt medical advice if you develop jaundice, a new migraine-type headache or a significant increase in blood pressure.
Warnings
Do Not Take Kliovance If You:
-
Have, have previously had or are suspected of having breast cancer.
-
Have a known or suspected oestrogen-dependent cancer.
-
Have unexplained vaginal bleeding.
-
Have untreated endometrial hyperplasia.
-
Have or have previously had a blood clot.
-
Have certain inherited blood-clotting disorders.
-
Have experienced a heart attack, stroke or angina.
-
Have liver disease where liver function has not returned to normal.
-
-
Are allergic to estradiol, norethisterone acetate or any other ingredient.
Consult Your Doctor Before Treatment If You Have:
-
Uterine fibroids or endometriosis.
-
High blood pressure or diabetes.
-
Migraines or severe headaches.
-
Gallstones or liver problems.
-
-
Heart or kidney conditions.
-
A family history of breast cancer.
-
An increased risk of blood clots.
-
Systemic lupus erythematosus.
-
High triglyceride levels.
-
A history of endometrial hyperplasia.
-
Lactose intolerance or certain inherited sugar-metabolism disorders.
Additional Safety Information
-
Kliovance is intended for women whose last natural menstrual period was at least 12 months ago.
-
It is not a contraceptive.
-
Do not use during pregnancy or breastfeeding.
-
Tell your doctor about other medicines and herbal supplements, including St John’s wort.
-
Some medicines used for epilepsy, tuberculosis and HIV may affect the effectiveness of HRT.
-
Inform your doctor before planned surgery. Treatment may need to be stopped approximately four to six weeks beforehand.
-
Attend regular HRT reviews and recommended breast screening.
-
Report vaginal bleeding that continues beyond the first six months, begins after six months of treatment or persists after stopping treatment.
Reviews
There are no reviews yet.